Viemed Healthcare (NASDAQ:VMD) Releases Earnings Results

Viemed Healthcare (NASDAQ:VMD) posted its quarterly earnings results on Wednesday. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.02, FiscalAI reports. Viemed Healthcare had a return on equity of 9.95% and a net margin of 5.34%.The firm had revenue of $76.18 million during the quarter, compared to analysts’ expectations of $77.70 million.

Viemed Healthcare Price Performance

VMD traded up $0.13 during trading on Wednesday, hitting $9.08. 211,795 shares of the company traded hands, compared to its average volume of 167,689. The company has a current ratio of 1.13, a quick ratio of 1.01 and a debt-to-equity ratio of 0.14. The company has a market cap of $345.22 million, a PE ratio of 27.52 and a beta of 1.23. The stock’s 50-day simple moving average is $7.82 and its two-hundred day simple moving average is $7.18. Viemed Healthcare has a 1 year low of $5.93 and a 1 year high of $9.20.

Institutional Investors Weigh In On Viemed Healthcare

Several large investors have recently made changes to their positions in VMD. Kemnay Advisory Services Inc. purchased a new stake in shares of Viemed Healthcare in the fourth quarter worth about $46,000. Quarry LP bought a new stake in Viemed Healthcare in the 3rd quarter worth approximately $48,000. AQR Capital Management LLC purchased a new stake in shares of Viemed Healthcare during the 1st quarter worth approximately $90,000. MetLife Investment Management LLC boosted its position in shares of Viemed Healthcare by 52.7% during the 4th quarter. MetLife Investment Management LLC now owns 18,565 shares of the company’s stock valued at $138,000 after acquiring an additional 6,408 shares during the last quarter. Finally, Invesco Ltd. grew its holdings in shares of Viemed Healthcare by 25.5% in the second quarter. Invesco Ltd. now owns 18,652 shares of the company’s stock valued at $129,000 after purchasing an additional 3,795 shares in the last quarter. 74.24% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. Wall Street Zen raised Viemed Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 14th. Weiss Ratings reissued a “hold (c)” rating on shares of Viemed Healthcare in a report on Monday, December 29th. Finally, Zacks Research upgraded shares of Viemed Healthcare to a “hold” rating in a report on Thursday, January 8th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the stock has a consensus rating of “Hold”.

About Viemed Healthcare

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.